The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …

Aims We aimed to briefly review the general characteristics of the novel coronavirus (SARS-
CoV-2) and provide a better understanding of the coronavirus disease (COVID-19) in people …

Methods We conducted a retrospective study involving all consecutive COVID-19 patients
with a definitive 28-day outcome and FBG measurement at admission from 24 January 2020 …

Background The prognostic significance of diabetes mellitus (DM) in patients with
coronavirus 2019 disease (COVID-19) remains unknown. Objectives To assess the risk of …

OBJECTIVE Diabetes is one of the most distinct comorbidities of COVID-19. Here, we
describe the clinical characteristics of and outcomes in patients with diabetes in whom …

OBJECTIVE Diabetes is common in COVID-19 patients and associated with unfavorable
outcomes. We aimed to describe the characteristics and outcomes and to analyze the risk …

Aim To evaluate the association between different degrees of hyperglycaemia and the risk of
all‐cause mortality among hospitalized patients with COVID‐19. Materials and Methods In a …

Although influenza is primarily considered a respiratory infection and causes significant
respiratory mortality, evidence suggests that influenza has an additional burden due to …

Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …